跳至主要内容
临床试验/NCT05431816
NCT05431816招募中不适用

Effect of Dietary Fiber Intervention on Patients With Polycystic Ovary Syndrome

Peking University Third Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Changes in ovarian volume

研究概览

简要总结

The purpose of the study is to understand the effect of dietary fiber on patients with polycystic ovary syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Individuals who are 20 to 40 years old, planning to become pregnant or infertile women.
  • Individuals who are diagnosed as PCOS according to Rotterdam PCOS diagnostic criteria: 1)oligomenorrhea or amenorrhea or irregular uterine bleeding 2) hyperandrogenism or hyperandrogenism; 3) ultrasonography showing polycystic ovary, while excluding other diseases that may cause hyperandrogenism and ovulation abnormalities. Meets at least two of the three criterias.
  • Individuals who can insist on continuous monitoring in the outpatient clinic,
  • Individuals who are not participating in other research projects currently or 3 months before the intervention.

排除标准

  • Individuals who suffering from other diseases that may cause hyperandrogenism and ovulation abnormalities.
  • Individuals who are during pregnant, lactation or menopause.
  • Individuals who currently receiving weight-loss drugs or surgery or within the past 2 months.
  • Individuals who suffer from infectious diseases such as hepatitis B, active tuberculosis, AIDS, etc.
  • Individuals who need regular medication to treat chronic diseases such as diabetes, hypertension, gout, hyperuricemia, etc.
  • Use of medications that affect hormone levels, appetite, carbohydrate absorption, and metabolism within the past 2 months.
  • Individuals with severe liver diseases or kidney disease that are ineligible to participate in the study.
  • A medical history of severe cardiovascular and cerebrovascular diseases.
  • Individuals who currently suffer from severe gastrointestinal diseases or undergo gastrointestinal resection that may affect nutrient absorption.
  • Individuals who drink more than 15g of alcohol per day or have a smoking habit.
  • Individuals who need drug treatment for any mental illness such as epilepsy and depression.
  • Cancer patients.

结局指标

主要结局

Changes in ovarian volume

时间窗: before and after 12 weeks of intervention

The size of each ovary will be determined using transvaginal ultrasonography for each participant in early follicular phase.

Changes in gut microbiota

时间窗: before and after 2,4,8,12 weeks of intervention

Study the gut microbiota change of stool samples between placebo group and intervention group

Changes in metabolomics

时间窗: before and after 2,4,8,12 weeks of intervention

Study the netabolomics change of stool samples between placebo group and intervention group

Changes in endocrine hormones

时间窗: before and after 12 weeks of intervention

Study the hormones change of blood samples between placebo group and intervention group

Changes in the number of follicles

时间窗: before and after 12 weeks of intervention

The number of follicles of each ovary will be determined using transvaginal ultrasonography for each participant in early follicular phase.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验